ENVIRI Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ENVIRI Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.24B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.34B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.37B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.13B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.85B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $1.53B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $1.20B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.35B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.31B | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $1.45B | Feb 21, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.24B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.34B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.37B | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.13B | Feb 20, 2025 |
| FY2021 | Dec 31, 2021 | $462.10M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $470.40M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $468.70M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $447.30M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $431.50M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $416.60M | Feb 24, 2022 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.61B | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $1.45B | Feb 22, 2018 |
| FY2017 | Dec 31, 2015 | $1.72B | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $2.07B | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $2.90B | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $3.05B | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $3.30B | Feb 27, 2014 |
| FY2012 | Dec 31, 2010 | $3.04B | Feb 26, 2013 |
| FY2011 | Dec 31, 2009 | $2.99B | Feb 28, 2012 |
| FY2010 | Dec 31, 2008 | $3.97B | Feb 24, 2011 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $79.70M | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $95.00M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $93.20M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $89.90M | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | $86.80M | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | $80.50M | Feb 24, 2022 |
| FY2021 | Jun 30, 2020 | $62.10M | Feb 24, 2022 |
| FY2021 | Mar 31, 2020 | $62.30M | Feb 24, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($167.60M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | ($129.65M) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | ($82.96M) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($180.07M) | Feb 20, 2025 |
| FY2021 | Dec 31, 2021 | ($24.40M) | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | $7.60M | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | $13.40M | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | $100.0K | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | ($6.30M) | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | ($9.60M) | Feb 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.25M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $30.71M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $87.51M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | ($100.90M) | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $88.38M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | ($3.31M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $76.40M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $130.70M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $104.66M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $64.88M | Feb 21, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.05M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $3.96M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $3.46M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $2.86M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $956.0K | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $534.0K | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $886.0K | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $3.93M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $2.74M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $4.28M | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $382.01M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $359.39M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $353.99M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $304.87M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $272.23M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $284.44M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $205.18M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $202.71M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $194.91M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $196.87M | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $101.41M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $78.06M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $114.45M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $150.53M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $72.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $53.82M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | ($163.0K) | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $192.02M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $176.89M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $159.88M | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $141.28M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $136.59M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $139.03M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $137.16M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $158.33M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $120.22M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $184.97M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $132.17M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $98.31M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $69.34M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.71B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.63B | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $2.83B | Feb 24, 2026 |
| FY2023 | Dec 31, 2022 | $2.79B | Feb 29, 2024 |
| FY2023 | Dec 31, 2021 | $3.05B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $2.99B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $2.37B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.63B | Feb 25, 2021 |
| FY2018 | Jan 1, 2018 | $1.54B | Feb 21, 2019 |
| FY2019 | Dec 31, 2017 | $1.58B | Feb 21, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.41B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $2.20B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $2.28B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $2.17B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.25B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $2.28B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.58B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.32B | Feb 21, 2020 |
| FY2018 | Jan 1, 2018 | $1.33B | Feb 21, 2019 |
| FY2018 | Dec 31, 2017 | $1.36B | Feb 21, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $255.06M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $391.52M | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $523.15M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $569.44M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $748.16M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $657.15M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $741.58M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $268.26M | Feb 21, 2020 |
| FY2018 | Jan 1, 2018 | $172.89M | Feb 21, 2019 |
| FY2018 | Dec 31, 2017 | $170.45M | Feb 21, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $758.68M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $739.76M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $780.98M | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | $772.28M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $883.11M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $889.05M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $725.34M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $404.71M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $394.92M | Feb 21, 2020 |
| FY2018 | Dec 31, 2016 | $382.25M | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.21B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.38B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.53B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.61B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.79B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.80B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.82B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.30B | Feb 21, 2020 |
| FY2018 | Jan 1, 2018 | $1.16B | Feb 21, 2019 |
| FY2018 | Dec 31, 2017 | $1.16B | Feb 21, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $103.67M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $88.36M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | $88.36M | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | $121.24M | Feb 24, 2026 |
| FY2022 | Dec 31, 2021 | $82.91M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $76.45M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $57.26M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $64.26M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $62.10M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $69.83M | Feb 22, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.56B | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | $1.43B | Feb 24, 2026 |
| FY2024 | Dec 31, 2023 | $1.42B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.35B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.37B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $1.28B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $778.16M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $592.15M | Feb 21, 2020 |
| FY2018 | Dec 31, 2017 | $593.66M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $673.41M | Feb 22, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 20, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | (1) | Feb 24, 2026 |
| FY2024 | Dec 31, 2022 | (2) | Feb 20, 2025 |
| FY2021 | Dec 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Jun 30, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Mar 31, 2021 | 0 | Feb 24, 2022 |
| FY2021 | Dec 31, 2020 | 0 | Feb 24, 2022 |
| FY2021 | Sep 30, 2020 | 0 | Feb 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 81.45M | Feb 24, 2026 |
| FY2025 | Dec 31, 2024 | 80.20M | Feb 24, 2026 |
| FY2025 | Dec 31, 2023 | 79.83M | Feb 24, 2026 |
| FY2025 | Dec 31, 2022 | 79.49M | Feb 24, 2026 |
| FY2024 | Dec 31, 2021 | 79.22M | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | 78.92M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | 78.51M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | 79.55M | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | 80.45M | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | 80.17M | Feb 21, 2020 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $0 | Feb 21, 2019 |
| FY2018 | Dec 31, 2017 | $0 | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $4.11M | Feb 21, 2019 |
| FY2017 | Dec 31, 2015 | $65.73M | Feb 22, 2018 |
| FY2016 | Dec 31, 2014 | $66.32M | Feb 24, 2017 |
| FY2015 | Dec 31, 2013 | $66.21M | Feb 26, 2016 |
| FY2014 | Dec 31, 2012 | $66.07M | Mar 2, 2015 |
| FY2013 | Dec 31, 2011 | $66.15M | Feb 27, 2014 |
| FY2012 | Dec 31, 2010 | $65.98M | Feb 26, 2013 |
| FY2011 | Dec 31, 2009 | $63.81M | Feb 28, 2012 |